N1-[(1S,2R)-1-benzyl-2-hydroxy-3-[[4-(hydroxymethyl)phenyl]sulfonyl-isobutyl-amino]propyl]-N3-methyl-N3-[(4-methyloxazol-2-yl)methyl]benzene-1,3-dicarboxamide | 1203560-66-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N1-[(1S,2R)-1-benzyl-2-hydroxy-3-[[4-(hydroxymethyl)phenyl]sulfonyl-isobutyl-amino]propyl]-N3-methyl-N3-[(4-methyloxazol-2-yl)methyl]benzene-1,3-dicarboxamide
• 英文别名: 1-N-[(2S,3R)-3-hydroxy-4-[[4-(hydroxymethyl)phenyl]sulfonyl-(2-methylpropyl)amino]-1-phenylbutan-2-yl]-3-N-methyl-3-N-[(4-methyl-1,3-oxazol-2-yl)methyl]benzene-1,3-dicarboxamide
• CAS: 1203560-66-0
• 化学式: C₃₅H₄₂N₄O₇S
• 分子量: 662.807
• InChiKey: PQWSVCGBIGOYSI-AJQTZOPKSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.7
• 重原子数：
  47
• 可旋转键数：
  15
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.34
• 拓扑面积：
  162
• 氢给体数：
  3
• 氢受体数：
  9

反应信息

• 作为产物：
  描述：

  间苯二甲酸单甲酯 在 lithium hydroxide monohydrate 、 sodium hydride 、 1-羟基苯并三唑 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 、 N,N-二异丙基乙胺 作用下， 以 四氢呋喃 、 甲醇 、 二氯甲烷 、 水 、 mineral oil 为溶剂， 反应 49.0h， 生成 N1-[(1S,2R)-1-benzyl-2-hydroxy-3-[[4-(hydroxymethyl)phenyl]sulfonyl-isobutyl-amino]propyl]-N3-methyl-N3-[(4-methyloxazol-2-yl)methyl]benzene-1,3-dicarboxamide
  参考文献：
  名称：

  Design of novel HIV-1 protease inhibitors incorporating isophthalamide-derived P2-P3 ligands: Synthesis, biological evaluation and X-ray structural studies of inhibitor-HIV-1 protease complex

  摘要：

  Based upon molecular insights from the X-ray structures of inhibitor-bound HIV-1 protease complexes, we have designed a series of isophthalamide-derived inhibitors incorporating substituted pyrrolidines, piperidines and thiazolidines as P2-P3 ligands for specific interactions in the S2-S3 extended site. Compound 4b has shown an enzyme K-i of 0.025 nM and antiviral IC50 of 69 nM. An X-ray crystal structure of inhibitor 4b-HIV-1 protease complex was determined at 1.33 angstrom resolution. We have also determined X-ray structure of 3b-bound HIV-1 protease at 1.27 angstrom resolution. These structures revealed important molecular insight into the inhibitor-HIV-1 protease interactions in the active site. (C) 2017 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2017.04.005

文献信息

• Structure-based design, synthesis, X-ray studies, and biological evaluation of novel HIV-1 protease inhibitors containing isophthalamide-derived P2-ligands
  作者：Arun K. Ghosh、Jun Takayama、Luke A. Kassekert、Jean-Rene Ella-Menye、Sofiya Yashchuk、Johnson Agniswamy、Yuan-Fang Wang、Manabu Aoki、Masayuki Amano、Irene T. Weber、Hiroaki Mitsuya

  DOI：10.1016/j.bmcl.2015.05.052

  日期：2015.11

  synthesis and biological evaluation of a series of novel HIV-1 protease inhibitors bearing isophthalamide derivatives as the P2–P3 ligands. We have investigated a range of acyclic and heterocyclic amides as the extended P2–P3 ligands. These inhibitors displayed good to excellent HIV-1 protease inhibitory activity. Also, a number of inhibitors showed very good antiviral activity in MT cells. Compound

  我们描述了一系列以间苯二甲酰胺衍生物作为P2-P3配体的新型HIV-1蛋白酶抑制剂的设计，合成和生物学评估。我们研究了一系列无环和杂环酰胺作为扩展的P2-P3配体。这些抑制剂表现出良好至优异的HIV-1蛋白酶抑制活性。同样，许多抑制剂在MT细胞中显示出非常好的抗病毒活性。化合物5n显示的酶K i为0.17 nM，抗病毒IC 50为14 nM。以1.11的分辨率测定了与HIV-1蛋白酶结合的抑制剂5o的X射线晶体结构。这种结构揭示了重要的分子洞察力，了解活性位点中的抑制剂与HIV-1蛋白酶的相互作用。
• NONPEPTIDE HIV-1 PROTEASE INHIBITORS
  申请人：Ghosh Arun K.

  公开号：US20110178123A1

  公开（公告）日：2011-07-21

  Novel compounds and compositions for treating patients in need of relief from HIV, AIDS, and AIDS-related diseases are described. Methods for treating HIV, AIDS, and AIDS-related diseases using the compounds described herein are also described.
• US8791135B2
  申请人：——

  公开号：US8791135B2

  公开（公告）日：2014-07-29
• US9085571B2
  申请人：——

  公开号：US9085571B2

  公开（公告）日：2015-07-21